Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Theranostics|September 15, 2021
Synthesis of precision antibody conjugates using proximity-induced chemistryYu J Cao, Chenfei Yu, Kuan-Lin Wu, et al.
Blood|August 18, 2022
A novel CD19/CD22/CD3 trispecific antibody enhances therapeutic efficacy and overcomes immune escape against B-ALLLijun Zhao, Shuhong Li, Xiaoyi Wei, et al.
Antibody Therapeutics|January 19, 2026
Unique loop-structured CD19/CD22 bispecific CAR-T-cell therapy for patients with relapsed/refractory diffuse large B-cell lymphoma: an observational studyShuhong Li, Liqiong Liu, Zelin Liu, et al.
ACS Synthetic Biology|April 15, 2021
Switchable CAR-T Cells Outperformed Traditional Antibody-Redirected Therapeutics Targeting Breast CancersYu J Cao, Xuechun Wang, Zhidong Wang, et al.
Cell Reports. Medicine|June 25, 2026
Design optimization of antibody-ligand motifs to enhance CAR-T redirection activity against solid tumorsXuechun Wang, Shuhong Li, Qiaoru Guo, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 24, 2019
A tumor-targeted immune checkpoint blockerYuhan Zhang, Changming Fang, Rongsheng E Wang, et al.
Theranostics|December 1, 2022
A Novel Her2/VEGFR2/CD3 trispecific antibody with an optimal structural design showed improved T-cell-redirecting antitumor efficacyDong Liu, Xuexiu Qi, Xiaoyi Wei, et al.
Science Advances|June 12, 2026
Targeting TMED4 enhances CD8<sup>+</sup> T cell function and CAR T cell efficacy in solid tumors through the IRE1α-autophagy axisHuizi Wang, Licai Shi, Ke Jiang, et al.
Frontiers in Medicine|April 16, 2025
Chinese expert consensus on the application of intravenous immunoglobulin in hematological diseasesZhi Guo, Jie Zhu, Jun Wang, et al.
Journal of Cancer Research and Therapeutics|August 29, 2024
Chinese guidelines for integrated diagnosis and treatment of intestinal microecology technologies in tumor application (2024 Edition)Qiang Wang, Mingxin He, Jing Liang, et al.
Pageof 3